Wholesale Dealers of Fingolimod - Favipiravir CAS 259793-96-9 T-705 COVID-19 API High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

We have our own product sales staff, style crew, technical group, QC staff and package staff. We now have strict high quality management procedures for each approach. Also, all of our workers are experienced in printing subject for (S)-3-Hydroxytetrahydrofuran, CAS 86728-85-0, Molecular Formula C20H18O8, And there are also a lot of overseas close friends who came for sight seeing, or entrust us to buy other stuff for them. You will be most welcome to come to China, to our city and to our manufacturing facility!

Wholesale Dealers of Fingolimod - Favipiravir CAS 259793-96-9 T-705 COVID-19 API High Quality – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply Favipiravir (CAS: 259793-96-9) and Related Intermediates:
Favipiravir CAS: 259793-96-9
3,6-Dichloropyrazine-2-Carbonitrile CAS: 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS: 356783-28-3
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS: 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS: 55321-99-8
2-Aminopropanediamide CAS: 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS: 13433-00-6

Chemical Name	Favipiravir
Synonyms	T-705; 6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide
CAS Number	259793-96-9
CAT Number	RF-API18
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C5H4FN3O2
Molecular Weight	157.1
Brand	Ruifu Chemical

Item	Specifications
Appearance	Off-White Powder
Identification	1) IR 2) HPLC
Melting Point	188.0℃-193.0℃
Related Substances (Area Normalization)	Any Single Impurity: ≤0.10% (HPLC)
Related Substances (Area Normalization)	Total Impurities: ≤1.0% (HPLC)
Purity / Analysis Method	≥99.0% (HPLC)
Moisture (K.F)	≤0.50%
Residue on Ignition	≤0.10%
Heavy Metals	≤20ppm
Residue Solvents
Methanol	≤3000ppm
Ethyl Acetate	≤5000ppm
Isopropanol	≤5000ppm
Acetonitrile	≤410ppm
n-Heptane	≤5000ppm
Test Standard	Enterprise Standard
Usage	Active Pharmaceutical Ingredient (API); Treatment of COVID-19

Package: Bottle, Aluminum foil bag, 25kg/Cardboard drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Favipiravir (T-705) (CAS 259793-96-9) is one of the 5 compounds recommended by WHO for the investigation of treatment of COVID-19.

Favipiravir (T-705) is a selective inhibitor of viral RNA-dependent RNA polymerase with activity against many RNA viruses, influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Favipiravir is a broad-spectrum antiviral drug that was cleared by the Drugs Controller General of India (DCGI) last week for “emergency restricted” use among Covid-19 patients. Favipiravir was originally developed in the late 1990s by a company that was later purchased by the Japanese firm Fujifilm as part of its transition from the photo business to healthcare. After being tested against a range of viruses, the drug was approved in Japan in 2014 for emergency use against flu epidemics or to treat new strains of influenza.

Product detail pictures:

Related Product Guide:

We believe that prolonged expression partnership is really a result of top of the range, value added support, rich encounter and personal contact for Wholesale Dealers of Fingolimod - Favipiravir CAS 259793-96-9 T-705 COVID-19 API High Quality – Ruifu , The product will supply to all over the world, such as: The Swiss, Thailand, Malta, We have gained a lot of recognition among customers spread all across the world. They trust us and always give repetitive orders. Furthermore, mentioned below are some of the major factors that have played significant role in our tremendous growth in this domain.